Alejandro Hernández-Solís, Servicio de Neumología y Cirugía de Tórax, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Andrea Quintana-Martínez, Servicio de Neumología y Cirugía de Tórax, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Arturo Reding-Bernal, Dirección de Investigación. Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Alejandro Hernández-de la Torriente, Servicio de Neumología y Cirugía de Tórax, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Pablo Álvarez-Maldonado, Servicio de Neumología y Cirugía de Tórax, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Objective: Throughout the COVID-19 pandemic, care protocols were created to apply in hospital units and care for the vulnerable populationin. The objetive was to describe clini- cal manifestations, comorbidity and mortality in cancer patients with SARS CoV-2 infection, as well as sanitary measures carried out in COVID centers. Method: Retrospective study of 1752 patients admitted to a respiratory care unit. Results: 5% of the population studied had a previous diagnosis of cancer; 59.1% were solid neoplasms and 40.9% hematologic neoplasms. Patients with cancer showed lower rates of admission to the intensive care unit (ICU) compared to patients without cancer (8% vs. 17.4%), with no differences in survival. Conclusions: Oncology patients hospitalized with COVID-19 did not have different survival rates and were less likely to require ICU care compared to non-cancer patients, this is likely due to multidisciplinary teamwork during the pandemic.
Keywords: Neoplasm. SARS Cov-2. Mortality.